InsidersTradesSigma
Track the 에이프로젠바이오로직스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에이프로젠바이오로직스 has recorded 13 insider filings. Market capitalisation: €28.5bn. The latest transaction was reported on 8 May 2026 (Sale). Among the most active insiders: 에이프로젠. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
Aprogen Biologics is a company focused on the development of biopharmaceutical products. It is listed on the XKRX market.